Výsledky vyhledávání - "Omeprazole/adverse effects"

The effect of ammonia on omeprazole-induced reduction of gastric acidity in subjects with Helicobacter pylori infection.

Autoři: Bercík, P. Verdú, E.F. Armstrong, D. a další

Témata: Adult, Ammonia/metabolism, Anti-Ulcer Agents/adverse effects, Anti-Ulcer Agents/therapeutic use, Female, Follow-Up Studies, Gastric Acidity Determination, Gastritis/drug therapy, Gastritis/microbiology, Helicobacter Infections/drug therapy, Helicobacter Infections/microbiology, Helicobacter pylori/drug effects, Helicobacter pylori/metabolism, Humans, Hydrogen-Ion Concentration, Male, Middle Aged, Omeprazole/adverse effects, Omeprazole/therapeutic use

Relation: The American Journal of Gastroenterology; https://iris.unil.ch/handle/iris/69655; serval:BIB_17597; 000086305400017

Dostupnost: https://iris.unil.ch/handle/iris/69655

A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease.

Autoři: Holtmann, G. Bytzer, P. Metz, M. a další

Témata: 2-Pyridinylmethylsulfinylbenzimidazoles, Adolescent, Adult, Aged, 80 and over, Benzimidazoles/administration & dosage, Benzimidazoles/adverse effects, Double-Blind Method, Endoscopy, Gastrointestinal, Female, Gastroesophageal Reflux/drug therapy, Heartburn/drug therapy, Humans, Male, Middle Aged, Omeprazole/administration & dosage, Omeprazole/adverse effects, Treatment Outcome

Relation: Alimentary Pharmacology and Therapeutics; https://iris.unil.ch/handle/iris/32823; serval:BIB_22738; 000174423800017

Dostupnost: https://iris.unil.ch/handle/iris/32823
https://doi.org/10.1046/j.1365-2036.2002.01207.x

Omeprazole-induced agranulocytosis in a kidney transplant recipient

Autoři: Gabutti, L. Stoller, R. Vogt, B.

Témata: Adult Agranulocytosis/*chemically induced Anti-Ulcer Agents/*adverse effects Humans *Kidney Transplantation Male Omeprazole/*adverse effects *Postoperative Complications

Relation: Nephrology Dialysis Transplantation; https://iris.unil.ch/handle/iris/191126; serval:BIB_A31ECA3D71CD; 000078636700069

Dostupnost: https://iris.unil.ch/handle/iris/191126
https://doi.org/10.1093/ndt/14.2.523

Evaluation of the effect of oral omeprazole on canine cerebrospinal fluid production: A pilot study

Autoři: Girod, Maud Allerton, F. Gommeren, Kris a další

Zdroj: The Veterinary Journal. 209:119-124

Témata: Electrophoresis, Male, Albumin quotient, High-resolution electrophoresis, Administration, Oral, Pilot Projects, Electrophoresis/veterinary, Proton Pump Inhibitors/adverse effects, 0403 veterinary science, Veterinary medicine & animal health, 03 medical and health sciences, Cerebrospinal fluid production, Dogs, 0302 clinical medicine, Nephelometry and Turbidimetry, Animals, Serum Albumin/analysis, Serum Albumin, Nephelometry and Turbidimetry/veterinary, Cerebrospinal Fluid, Cerebrospinal Fluid/drug effects/secretion, Proton Pump Inhibitors, 04 agricultural and veterinary sciences, Anti-Ulcer Agents, Life sciences, Médecine vétérinaire & santé animale, Omeprazole/adverse effects, 3. Good health, Dogs/cerebrospinal fluid, Anti-Ulcer Agents/adverse effects, Sciences du vivant, Female, Biomarkers/blood, Nephelometry, Biomarkers, Omeprazole

Přístupová URL adresa: https://orbi.uliege.be/bitstream/2268/213401/1/1-s2.0-S1090023315004566-main.pdf
https://pubmed.ncbi.nlm.nih.gov/26852945
https://www.ncbi.nlm.nih.gov/pubmed/26852945
https://orbi.uliege.be/handle/2268/213401
https://www.sciencedirect.com/science/article/pii/S1090023315004566
https://pubmed.ncbi.nlm.nih.gov/26852945/
https://core.ac.uk/display/85257742
https://www.cabdirect.org/cabdirect/abstract/20163121707

Healing Effects of Rebamipide and Omeprazole in Helicobacter pylori-Positive Gastric Ulcer Patients after Eradication Therapy: A Randomized Double-Blind, Multinational, Multi-Institutional Comparative Study

Autoři: Zhi Zheng Ge Dai Ming Fan Yong Chan Lee a další

Přispěvatelé: Zhi Zheng Ge Dai Ming Fan Yong Chan Lee a další

Zdroj: Digestion. 84:221-229

Témata: Helicobacter Infections/drug therapy, Adult, Male, Alanine/analogs & derivatives, Quinolones/therapeutic use, Proton pump inhibitor, Quinolones, Helicobacter Infections, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Clarithromycin, 80 and over, Humans, Stomach Ulcer, Rebamipide, Amoxicillin/therapeutic use, Clarithromycin/therapeutic use, Aged, Aged, 80 and over, Wound Healing, Quinolones/adverse effects, Alanine, Helicobacter pylori, Gastric ulcer, Stomach Ulcer/drug therapy, Stomach Ulcer/pathology, Alanine/therapeutic use, Amoxicillin, Middle Aged, Anti-Ulcer Agents, Stomach Ulcer/microbiology, Omeprazole/adverse effects, Anti-Bacterial Agents, Intention to Treat Analysis, 3. Good health, Anti-Bacterial Agents/therapeutic use, Treatment Outcome, Treatment efficacy, Alanine/adverse effects, Female, Helicobacter Infections/microbiology, Omeprazole/therapeutic use, Anti-Ulcer Agents/therapeutic use, Omeprazole

Popis souboru: 221~229

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/21757914
https://koreauniv.pure.elsevier.com/en/publications/healing-effects-of-rebamipide-and-omeprazole-in-helicobacter-pylo
https://europepmc.org/article/MED/21757914
https://pubmed.ncbi.nlm.nih.gov/21757914/
https://yonsei.pure.elsevier.com/en/publications/healing-effects-of-rebamipide-and-omeprazole-in-helicobacter-pylo
https://www.ncbi.nlm.nih.gov/pubmed/21757914
https://mdanderson.influuent.utsystem.edu/en/publications/healing-effects-of-rebamipide-and-omeprazole-in-helicobacter-pylo

Effect of esomeprazole triple therapy on eradication rates of Helicobacter pylori, gastric ulcer healing and prevention of relapse in gastric ulcer patients

Autoři: Tchernev, K Wrangstadh, M Malfertheiner, P a další

Zdroj: European Journal of Gastroenterology & Hepatology. 20:526-536

Témata: Adult, Male, Severity of Illness Index, Helicobacter Infections, Recurrence - prevention & control, Young Adult, Drug Therapy, Double-Blind Method, Clarithromycin, Anti-Bacterial Agents - adverse effects - therapeutic use, Gastroscopy, Secondary Prevention, Humans, Stomach Ulcer, Anti-Ulcer Agents - adverse effects - therapeutic use, Stomach Ulcer - drug therapy - microbiology - prevention & control, Helicobacter Infections - complications - drug therapy, Helicobacter pylori, Clarithromycin - adverse effects - therapeutic use, Amoxicillin, Esomeprazole, Middle Aged, Anti-Ulcer Agents, Anti-Bacterial Agents, 3. Good health, Treatment Outcome, Combination, Drug Therapy, Combination, Female, Helicobacter pylori - drug effects - isolation & purification, Omeprazole - adverse effects - therapeutic use, Amoxicillin - adverse effects - therapeutic use

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/18467912
https://insights.ovid.com/crossref?an=00042737-200806000-00010
http://hub.hku.hk/handle/10722/77885
http://journals.lww.com/00042737-200806000-00010
https://is.muni.cz/publication/837872/cs/Effect-of-esomeprazole-triple-therapy-on-eradication-rates-of-Helicobacter-pylori-gastric-ulcer-healing-and-prevention-of-relapse-in-gastric-ulcer-patients/Tulassay-Stolte-Sjolund-Engstrand
https://insights.ovid.com/european-gastroenterology-hepatology/ejghe/2008/06/000/effect-esomeprazole-triple-therapy-eradication/10/00042737
https://pubmed.ncbi.nlm.nih.gov/18467912/
http://hdl.handle.net/10722/77885

Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial

Autoři: Chow, DKL To, KF Leung, WK a další

Zdroj: The Lancet. 369:1621-1626

Témata: Male, Cyclooxygenase Inhibitors - Adverse Effects - Therapeutic Use, Anti-Inflammatory Agents, Non-Steroidal - Adverse Effects - Therapeutic Use, Anti-Ulcer Agents - Adverse Effects - Therapeutic Use, 03 medical and health sciences, 0302 clinical medicine, Drug Therapy, Double-Blind Method, Risk Factors, Osteoarthritis, Recurrence - Prevention & Control, Secondary Prevention, Humans, Cyclooxygenase Inhibitors, Aged, Sulfonamides, Proton Pumps - Antagonists & Inhibitors, Sulfonamides - Adverse Effects - Therapeutic Use, Anti-Inflammatory Agents, Non-Steroidal, Anti-Inflammatory Agents, Non-Steroidal - Adverse Effects - Therapeutic Use, Omeprazole - Adverse Effects - Therapeutic Use, Esomeprazole, Proton Pump Inhibitors, Peptic Ulcer Hemorrhage - Chemically Induced - Prevention & Control - Therapy, Osteoarthritis - Drug Therapy, Anti-Ulcer Agents, 3. Good health, Peptic Ulcer Hemorrhage, Treatment Outcome, Pyrazoles - Adverse Effects - Therapeutic Use, Celecoxib, Combination, Pyrazoles, Drug Therapy, Combination, Female

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/17499604
https://www.sciencedirect.com/science/article/pii/S0140673607607491
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(07)60749-1/fulltext
http://hub.hku.hk/handle/10722/163078
https://europepmc.org/article/MED/17499604
http://www-users.york.ac.uk/~mb55/msc/clinbio/exam/chan2007.pdf
http://www.sciencedirect.com/science/article/pii/S0140673607607491
http://hdl.handle.net/10722/163078

Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients

Autoři: Wong, BCY Hung, WK Yee, YK a další

Zdroj: Gut. 51:502-506

Témata: Adult, Male, 0301 basic medicine, China, Helicobacter infections - complications, Adolescent, 2-Pyridinylmethylsulfinylbenzimidazoles, Drug Administration Schedule, Helicobacter Infections, 03 medical and health sciences, 0302 clinical medicine, Dyspepsia - complications - drug therapy - microbiology, Double-Blind Method, Anti-bacterial agents - adverse effects - therapeutic use, Humans, Lansoprazole, Dyspepsia, Aged, Helicobacter pylori, Middle Aged, Anti-Ulcer Agents, Anti-Bacterial Agents, 3. Good health, Omeprazole - adverse effects - analogs & derivatives - therapeutic use, Quality of Life, Female, Anti-ulcer agents - therapeutic use, Omeprazole

Popis souboru: 190114 bytes; 28672 bytes; 4936 bytes; application/pdf; application/msword; text/plain

Přístupová URL adresa: https://gut.bmj.com/content/51/4/502.full.pdf
https://pubmed.ncbi.nlm.nih.gov/12235071
https://core.ac.uk/display/37882407
http://hub.hku.hk/handle/10722/43105
https://www.ncbi.nlm.nih.gov/pmc/articles/1773405/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1773405/
https://europepmc.org/article/MED/12235071
https://gut.bmj.com/content/51/4/502.full.pdf
http://hdl.handle.net/10722/43105

Rabeprazole‐based 3‐day and 7‐day triple therapy vs. omeprazole‐based 7‐day triple therapy for the treatment of Helicobacter pylori infection

Autoři: Yip, AWC Lam, SK Hui, CK a další

Zdroj: Alimentary Pharmacology & Therapeutics. 15:1959-1965

Témata: Adult, Diarrhea, Male, Time Factors, Drug Resistance, Anti-Ulcer Agents - Adverse Effects - Therapeutic Use, Exanthema - Chemically Induced, 80 And Over, 2-Pyridinylmethylsulfinylbenzimidazoles, Helicobacter Infections, 03 medical and health sciences, 0302 clinical medicine, Drug Therapy, Diarrhea - Chemically Induced, Humans, Aged, Aged, 80 and over, Proton-Translocating Atpases - Antagonists & Inhibitors, Helicobacter pylori, Helicobacter Pylori - Drug Effects - Isolation & Purification, Omeprazole - Adverse Effects - Therapeutic Use, Exanthema, Middle Aged, Aged, 80 And Over, Anti-Ulcer Agents, Benzimidazoles - Adverse Effects - Therapeutic Use, Duodenal Ulcer - Prevention & Control, 3. Good health, Stomach Ulcer - Prevention & Control, Proton-Translocating ATPases, Treatment Outcome, Duodenal Ulcer, Rabeprazole, Combination, Benzimidazoles, Drug Therapy, Combination, Female, Helicobacter Infections - Drug Therapy - Microbiology, Omeprazole

Přístupová URL adresa: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2036.2001.01118.x
https://pubmed.ncbi.nlm.nih.gov/11736727
https://hub.hku.hk/handle/10722/162544
https://pubmed.ncbi.nlm.nih.gov/11736727/
https://core.ac.uk/display/37982957
https://onlinelibrary.wiley.com/doi/full/10.1046/j.1365-2036.2001.01118.x
http://hdl.handle.net/10722/162544

Triple therapy with clarithromycin, omeprazole, and amoxicillin for eradication of Helicobacter pylori in duodenal ulcer patients in Asia and Africa

Autoři: Wong, B. C. Y. Chang, F. Y. Abid, S. a další

Zdroj: Alimentary Pharmacology & Therapeutics. 14:1529-1535

Témata: drug safety, diarrhea, drug response, gastrointestinal endoscopy, South Africa, 0302 clinical medicine, Pakistan, Anti-Ulcer Agents - adverse effects - therapeutic use, Helicobacter Infections - complications - drug therapy, amoxicillin, adult, Clarithromycin - adverse effects - therapeutic use, article, clinical trial, duodenum ulcer, clarithromycin, nausea, 3. Good health, Anti-Bacterial Agents, aged, Treatment Outcome, priority journal, Combination, Hong Kong, Drug Therapy, Combination, Omeprazole, Asia, Taiwan, Penicillins, Duodenal Ulcer - complications - drug therapy, ulcer healing, omeprazole, Helicobacter Infections, vertigo, 03 medical and health sciences, Drug Therapy, Clarithromycin, Anti-Bacterial Agents - adverse effects - therapeutic use, Humans, human, Penicillins - adverse effects - therapeutic use, Helicobacter pylori, Amoxicillin, Anti-Ulcer Agents, major clinical study, taste disorder, drug efficacy, Gram negative infection, Duodenal Ulcer, Africa, treatment outcome, Omeprazole - adverse effects - therapeutic use, Amoxicillin - adverse effects - therapeutic use

Přístupová URL adresa: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2036.2000.00863.x
https://pubmed.ncbi.nlm.nih.gov/11069326
https://pubmed.ncbi.nlm.nih.gov/11069326/
https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2036.2000.00863.x
http://www.ptolemy.ca/members/archives/2007/ulcer/docs/wong2000.pdf
http://hub.hku.hk/handle/10722/76901
https://www.ncbi.nlm.nih.gov/pubmed/11069326
https://scholar.sun.ac.za:443/handle/10019.1/13274
http://hdl.handle.net/10722/76901

Triple therapy for Helicobacter pylori eradication is more effective than long‐term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long‐term follow‐up study

Autoři: Wong, BCY Lai, KC Hu, WHC a další

Zdroj: Alimentary Pharmacology & Therapeutics. 13:303-309

Témata: Adult, Male, Sucralfate, Anti-Bacterial Agents - Adverse Effects - Therapeutic Use, Anti-Ulcer Agents - Adverse Effects - Therapeutic Use, Helicobacter Infections, 03 medical and health sciences, 0302 clinical medicine, Drug Therapy, Metronidazole - Adverse Effects - Therapeutic Use, Clarithromycin, Metronidazole, Recurrence - Prevention & Control, Secondary Prevention, Humans, Urea, Duodenal Ulcer - Drug Therapy - Microbiology - Prevention & Control, Prospective Studies, Urea - Metabolism, Helicobacter pylori, Omeprazole - Adverse Effects - Therapeutic Use, Helicobacter Pylori - Drug Effects, Middle Aged, Anti-Ulcer Agents, 3. Good health, Anti-Bacterial Agents, Breath Tests, Duodenal Ulcer, Combination, Clarithromycin - Adverse Effects - Therapeutic Use, Sucralfate - Adverse Effects - Therapeutic Use, Drug Therapy, Combination, Female, Helicobacter Infections - Drug Therapy - Microbiology, Omeprazole, Follow-Up Studies

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/10102962
https://pubmed.ncbi.nlm.nih.gov/10102962/
https://core.ac.uk/display/37982429
https://hub.hku.hk/handle/10722/162270
https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2036.1999.00477.x
https://europepmc.org/article/MED/10102962
https://onlinelibrary.wiley.com/doi/full/10.1046/j.1365-2036.1999.00477.x
http://hdl.handle.net/10722/162270

Letter to the Editor : Is Omeprazole a contributing risk factor for osteoarthritis (OA)?

Autoři: Zhang, Haoyang Chen, Yongping Zhou, Liangbin a další

Zdroj: Journal of Translational Medicine; 22, pp 1-3 (2024) ; ISSN: 1479-5876

Témata: Cardiology and Cardiovascular Disease, Humans, Osteoarthritis/drug therapy, Risk Factors, Omeprazole/adverse effects

Relation: pmid:39390527; scopus:85206038241

Dostupnost: https://lup.lub.lu.se/record/7d2c0ff0-d3b6-4a0f-8712-aeb2f9bbde2d
https://doi.org/10.1186/s12967-024-05525-9

Omeprazole hypersensitivity / Överkänslighet mot omeprazol

Autoři: Wikström Jonsson, E Vitols, S

Zdroj: Läkartidningen. 101(19):1722

Granulocytopenia as adverse effect of Plavix or Lanzo / Granulocytopeni som biverkan av Plavix eller Lanzo

Autoři: Von Euler, M Böttiger, Y

Zdroj: Läkartidningen. 100(51-52):4323

A cytochrome P450 phenotyping cocktail causing unexpected adverse reactions in female volunteers

Autoři: Per Damkier Rasmus Steen Pedersen Mette Marie Hougaard Christensen a další

Zdroj: Pedersen, R S, Damkier, P, Hougaard Christensen, M M & Brosen, K 2013, ' A cytochrome P450 phenotyping cocktail causing unexpected adverse reactions in female volunteers ', European Journal of Clinical Pharmacology, vol. 69, no. 12, pp. 1997-1999 . https://doi.org/10.1007/s00228-013-1561-1

Témata: Adult, Male, Cross-Over Studies, Genotype, Cytochrome P-450 Enzyme System/genetics, Middle Aged, Losartan/adverse effects, Healthy Volunteers, Losartan, Omeprazole/adverse effects, 3. Good health, Tramadol/adverse effects, Drug Combinations, Young Adult, 03 medical and health sciences, Caffeine/adverse effects, Phenotype, 0302 clinical medicine, Cytochrome P-450 Enzyme System, Caffeine, Humans, Female, Omeprazole, Tramadol

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/23917460
https://pubmed.ncbi.nlm.nih.gov/23917460/
https://rd.springer.com/article/10.1007/s00228-013-1561-1
https://link.springer.com/article/10.1007/s00228-013-1561-1
https://link.springer.com/article/10.1007/s00228-013-1561-1/fulltext.html
https://core.ac.uk/display/50692495
https://www.ncbi.nlm.nih.gov/pubmed/23917460
https://portal.findresearcher.sdu.dk/da/publications/bce14d70-84ef-4519-927a-ca1aea36d052
https://portal.findresearcher.sdu.dk/da/publications/bce14d70-84ef-4519-927a-ca1aea36d052
https://doi.org/10.1007/s00228-013-1561-1

It is possible to reduce drug-drug interactions. Interactions were corrected frequently by patient-specific letters to general practitioners / Det går att minska D-interaktioner. Interaktioner åtgärdades ofta efter patientspecifika brev till allmänläkare

Autoři: Quittenbaum, Stephan Cronberg, Olof Nordquist, Cecilia

Zdroj: Läkartidningen. 110(48):2176

Can long time treatment with proton pump inhibitors inhibit the iron absorption? / Kan långvarig behandling med protonpumpshämmare hämma järnabsorptionen

Autoři: Olsson, R

Zdroj: Information från Läkemedelsverket. 12(1):25

Colitis and lansoprazole / Kolit och lansoprazol

Autoři: Blomgren, K Eliasson, E Bergman, J a další

Zdroj: Information från Läkemedelsverket. 12(6):22

The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis.

Přispěvatelé: Chan Hyuk Park Eun Hye Kim Yun Ho Roh a další

Zdroj: T201405469.pdf

Témata: 2-Pyridinylmethylsulfinylbenzimidazoles/adverse effects, Dexlansoprazole/adverse effects, Esomeprazole/adverse effects, Humans, Lansoprazole/adverse effects, Magnesium/blood, Odds Ratio, Omeprazole/adverse effects, Proton Pump Inhibitors/adverse effects, Rabeprazole/adverse effects, Risk Factors, Treatment Outcome

Popis souboru: e112558

Relation: PLOS ONE; J02540; https://ir.ymlib.yonsei.ac.kr/handle/22282913/138687; T201405469; PLOS ONE, Vol.9(11) : e112558, 2014; 57344

Dostupnost: https://ir.ymlib.yonsei.ac.kr/handle/22282913/138687
https://doi.org/10.1371/journal.pone.0112558

Losec was probably the cause of interstitial nephritis / Losec var trolig orsak till interstitiell nefrit

Autoři: Jacobson, S H Sundelin, B

Zdroj: Läkartidningen. 96(14):1717